| CAT | AP50635-A |
| CAS | 50-63-5 |
| Structure: |  |
| MDL Number | MFCD00069852 |
| Molecular Weight | 515.86 |
| EC Number | 200-055-2 |
| InChI Key | QKICWELGRMTQCR-UHFFFAOYSA-N |
| REAXYS Number | 4223142 |
| Description | Pharmaceutical Secondary Standard; Certified Reference Material |
| MP | 200 °C (dec.) (lit.) |
| Size | 1G |
| Form | neat |
| Grade | certified reference material; pharmaceutical secondary standard |
1[Expert Consensus on Chloroquine Phosphate for the Treatment of Novel Coronavirus Pneumonia]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 20;43(0):E019.
PMID: 32075365
1Chloroquine for Influenza Prevention: A Randomised, Double-Blind, Placebo Controlled Trial
Nicholas I Paton, Lawrence Lee, Ying Xu, Eng Eong Ooi, Yin Bun Cheung, Sophia Archuleta, Gerard Wong, Annelies Wilder-Smith
Lancet Infect Dis. 2011 Sep;11(9):677-83.
PMID: 21550310
1Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection
Yin-Xiao Du, Xiao-Ping Chen
Clin Pharmacol Ther. 2020 Apr 4.
PMID: 32246834
1In Vitro Inhibition of Severe Acute Respiratory Syndrome Coronavirus by Chloroquine
Els Keyaerts, Leen Vijgen, Piet Maes, Johan Neyts, Marc Van Ranst
Biochem Biophys Res Commun. 2004 Oct 8;323(1):264-8.
PMID: 15351731
or fill out the following form.